What does CUSIP 45408X308 represent in this 13F holders report?

CUSIP 45408X308 is the security identifier for IGC - IGC Pharma, Inc. - COM NEW used to aggregate holder disclosures.

How many institutions held IGC - IGC Pharma, Inc. - COM NEW in Q4 2020?

20 institutional investors reported IGC - IGC Pharma, Inc. - COM NEW for Q4 2020. Use the holders table for investor-level position and value details.

IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / COM NEW
Total 13F shares: 3,256,530
Share change: +1,154,835
Total reported value: $5,077,000
Put/Call ratio: 151%
Price per share: $1.56
Number of holders: 20
Value change: +$1,886,338
Number of buys: 11
Number of sells: 7

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 45408X308:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Carroll Financial Associates, Inc.	13F	Company	— class O/S missing	515,000	$535,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	470,431	$489,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	261,671	$272,000	—	30 Sep 2020	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	192,200	$200,000	—	30 Sep 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	143,855	$150,000	—	30 Sep 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	110,622	$115,000	—	30 Sep 2020	13F
DEARBORN PARTNERS LLC	13F	Company	— class O/S missing	96,901	$101,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	84,533	$88,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	66,280	$69,000	—	30 Sep 2020	13F
TRUIST FINANCIAL CORP	13F	Company	— class O/S missing	36,667	$38,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	27,826	$29,000	—	30 Sep 2020	13F
Sowell Financial Services LLC	13F	Company	— class O/S missing	25,305	$26,000	—	30 Sep 2020	13F
Powell Investment Advisors, LLC	13F	Company	— class O/S missing	25,000	$26,000	—	30 Sep 2020	13F
UBS Group AG	13F	Company	— class O/S missing	14,157	$15,000	—	30 Sep 2020	13F
SIMPLEX TRADING, LLC	13F	Company	— class O/S missing	12,042	$12,000	—	30 Sep 2020	13F
Cutler Group LLC / CA	13F	Company	— class O/S missing	5,100	$5,000	—	30 Sep 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	4,755	$5,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	— class O/S missing	4,750	$5,000	—	30 Sep 2020	13F
Geneos Wealth Management Inc.	13F	Company	— class O/S missing	3,200	$3,000	—	30 Sep 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	1,000	$1,000	—	30 Sep 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	500	$1,000	—	30 Sep 2020	13F

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2020

As of 31 Dec 2020, IGC Pharma, Inc. - COM NEW (IGC) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,256,530 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Carroll Financial Associates, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, DEARBORN PARTNERS LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, and TRUIST FINANCIAL CORP. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.